The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis - PubMed (original) (raw)
The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis
Dalia Barsyte-Lovejoy et al. Cancer Res. 2006.
Free article
Abstract
The product of the MYC oncogene is widely deregulated in cancer and functions as a regulator of gene transcription. Despite an extensive profile of regulated genes, the transcriptional targets of c-Myc essential for transformation remain unclear. In this study, we show that c-Myc significantly induces the expression of the H19 noncoding RNA in diverse cell types, including breast epithelial, glioblastoma, and fibroblast cells. c-Myc binds to evolutionarily conserved E-boxes near the imprinting control region to facilitate histone acetylation and transcriptional initiation of the H19 promoter. In addition, c-Myc down-regulates the expression of insulin-like growth factor 2 (IGF2), the reciprocally imprinted gene at the H19/IGF2 locus. We show that c-Myc regulates these two genes independently and does not affect H19 imprinting. Indeed, allele-specific chromatin immunoprecipitation and expression analyses indicate that c-Myc binds and drives the expression of only the maternal H19 allele. The role of H19 in transformation is addressed using a knockdown approach and shows that down-regulation of H19 significantly decreases breast and lung cancer cell clonogenicity and anchorage-independent growth. In addition, c-Myc and H19 expression shows strong association in primary breast and lung carcinomas. This work indicates that c-Myc induction of the H19 gene product holds an important role in transformation.
Similar articles
- Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats.
Dragan YP, Sargent LM, Babcock K, Kinunen N, Pitot HC. Dragan YP, et al. Mol Carcinog. 2004 Jul;40(3):150-9. doi: 10.1002/mc.20029. Mol Carcinog. 2004. PMID: 15224347 - Down-regulation of the IGF-2/H19 locus during normal and malignant hematopoiesis is independent of the imprinting pattern.
Tessema M, Länger F, Bock O, Seltsam A, Metzig K, Hasemeier B, Kreipe H, Lehmann U. Tessema M, et al. Int J Oncol. 2005 Feb;26(2):499-507. Int J Oncol. 2005. PMID: 15645136 - Growth factor-dependent regulation of survivin by c-myc in human breast cancer.
Cosgrave N, Hill AD, Young LS. Cosgrave N, et al. J Mol Endocrinol. 2006 Dec;37(3):377-90. doi: 10.1677/jme.1.02118. J Mol Endocrinol. 2006. PMID: 17170079 - The H19 gene: regulation and function of a non-coding RNA.
Gabory A, Ripoche MA, Yoshimizu T, Dandolo L. Gabory A, et al. Cytogenet Genome Res. 2006;113(1-4):188-93. doi: 10.1159/000090831. Cytogenet Genome Res. 2006. PMID: 16575179 Review. - The H19 locus: role of an imprinted non-coding RNA in growth and development.
Gabory A, Jammes H, Dandolo L. Gabory A, et al. Bioessays. 2010 Jun;32(6):473-80. doi: 10.1002/bies.200900170. Bioessays. 2010. PMID: 20486133 Review.
Cited by
- Competing endogenous RNAs regulatory crosstalk networks: The messages from the RNA world to signaling pathways directing cancer stem cell development.
Aria H, Azizi M, Nazem S, Mansoori B, Darbeheshti F, Niazmand A, Daraei A, Mansoori Y. Aria H, et al. Heliyon. 2024 Jul 26;10(15):e35208. doi: 10.1016/j.heliyon.2024.e35208. eCollection 2024 Aug 15. Heliyon. 2024. PMID: 39170516 Free PMC article. Review. - lncRNAs regulate cell stemness in physiology and pathology during differentiation and development.
Lu J, Xu L, Wang Y, Guan B. Lu J, et al. Am J Stem Cells. 2024 Apr 25;13(2):59-74. doi: 10.62347/VHVU7361. eCollection 2024. Am J Stem Cells. 2024. PMID: 38765805 Free PMC article. Review. - Chuanxiong Rhizoma extracts prevent liver fibrosis via targeting CTCF-c-MYC-H19 pathway.
Li Y, Li F, Ding M, Ma Z, Li S, Qu J, Li X. Li Y, et al. Chin Herb Med. 2023 Nov 28;16(1):82-93. doi: 10.1016/j.chmed.2023.07.003. eCollection 2024 Jan. Chin Herb Med. 2023. PMID: 38375042 Free PMC article. - C-Myc/H19/miR-29b axis downregulates nerve/glial (NG)2 expression in glioblastoma multiforme.
Boewe AS, Wrublewsky S, Hoppstädter J, Götz C, Kiemer AK, Menger MD, Laschke MW, Ampofo E. Boewe AS, et al. Mol Ther Nucleic Acids. 2024 Jan 12;35(1):102120. doi: 10.1016/j.omtn.2024.102120. eCollection 2024 Mar 12. Mol Ther Nucleic Acids. 2024. PMID: 38318212 Free PMC article. - Involvement of FAM170B-AS1, hsa-miR-1202, and hsa-miR-146a-5p in breast cancer.
Abd ELhafeez AS, Ghanem HM, Swellam M, Taha AM. Abd ELhafeez AS, et al. Cancer Biomark. 2024;39(4):313-333. doi: 10.3233/CBM-230396. Cancer Biomark. 2024. PMID: 38250762 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous